6:24 PM
 | 
Jun 28, 2013
 |  BC Extra  |  Company News

FDA approves non-hormonal menopause product

FDA approved an NDA for Brisdelle paroxetine from the Noven Pharmaceuticals Inc. subsidiary of Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530; Osaka:4530) to treat moderate...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >